Anzeige
Mehr »
Dienstag, 10.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
154 Leser
Artikel bewerten:
(0)

NCQA Kicks Off Inaugural Learning Collaborative to Measure Patient Engagement

Leading healthcare organizations inform and shape best practices in digital wellness, condition management and patient engagement strategies.

WASHINGTON, D.C. / ACCESS Newswire / February 10, 2026 / The National Committee for Quality Assurance (NCQA) officially launched its Measuring Patient Engagement Learning Collaborative as part of a series designed to explore how healthcare organizations should assess, manage and deliver digitally-enabled interventions to support effective condition management and well-being. NCQA is convening 13 organizations from across the health ecosystem, representing health plans, vendors, clinicians and policymakers. The learning collaborative is also charged with advising and testing measures of patient engagement for NCQA's new Wellness and Condition Management Program, which aims to promote high-quality digitally enabled patient engagement solutions to support effective self-management of chronic conditions and improve overall well-being. The Collaborative's work will ultimately inform the quality approaches along this pathway, specifically how engagement is defined and measured, and what the associated outcomes for that engagement look like in real-world scenarios. Thus, the primary impact is to improve overall care of patient populations across the risk continuum.

NCQA is honored to partner with the following organizations as part of the Measuring Patient Engagement Learning Collaborative:

Advisory Partners: Agency for Healthcare Research & Quality, American Academy of Family Physicians, AmeriHealth Caritas, HealthTalk A.I., Humana, Omada Health, Purchaser Business Group on Health, South Carolina Office of Rural Health and Washington State Health Care Authority.

Data Testing Partners: GetSetUp, GoMo Health, Intermountain Health, and Ovia Health by Labcorp.

These measurement concepts will be integrated into the Wellness and Condition Management program through health risk assessments and clinical integration, with patient engagement as a crosscutting theme.

"The work of this learning collaborative is a core part of our population health strategy," said Rachel Harrington, PhD, Senior Product Strategist, NCQA. "We know that we will not see the improvement in health outcomes that we need to see as a society or as a healthcare system by focusing only within the four walls of clinical care. Meeting people where they are, understanding how people want to engage with their health and well-being and focusing on supporting healthy behaviors are critical components to improving healthcare quality."

This learning collaborative is funded in part by The Leona M. and Harry B. Helmsley Charitable Trust. Diabetes is a significant and persistent health issue in the United States. Thirty-eight million Americans live with diabetes, and 1.2 million cases are newly diagnosed each year (CDC).1 Type 1 diabetes accounts for about 5-10% of cases, while type 2 accounts for 90-95% of cases. With generous support from the Helmsley Charitable Trust, NCQA will ground the Learning Collaborative in real-world experiences by exploring the nuances of measurement and implications for engagement in specific populations, including patients living with type 1 and type 2 diabetes.

About NCQA

NCQA is an independent nonprofit organization that defines and drives healthcare quality through accreditation, standards, performance measurement, and expert support. For more than 35 years, NCQA has advanced transparency, accountability, and enabled healthcare organizations to deliver better outcomes for patients. NCQA's Healthcare Effectiveness Data and Information Set (HEDIS2) is one of healthcare's most widely used performance improvement tools. Learn more at ncqa.org. Follow NCQA on X @ncqa and on LinkedIn linkedin.com/company/ncqa.

# # #

Media Contact

Shift Communications
NCQA@shiftcomm.com

1https://www.cdc.gov/diabetes/about/index.html

2 HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA)

SOURCE: NCQA



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ncqa-kicks-off-inaugural-learning-collaborative-to-measure-patient-en-1135405

© 2026 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.